UNITED STATES OF AMERICA v. TEVA PHARMACEUTICALS USA, INC. et al

  1. November 18, 2020

    Feds Urge Court Not To Ax $300M Teva Kickback Case

    The federal government says Teva Pharmaceuticals USA Inc. shouldn't be able to dodge a suit claiming the company used two copay foundations to funnel illegal kickbacks to Medicare patients using its multiple sclerosis drug, arguing the suit sufficiently lays out a purported "long-running scheme."

  2. September 17, 2020

    Feds Resist Merging Kickback Suits Against Teva, Regeneron

    Massachusetts federal prosecutors are trying to ensure that two False Claims Act suits accusing Teva Pharmaceuticals USA and Regeneron Pharmaceuticals of illegally paying charitable foundations to cover copays for its drugs are kept separate.

  3. August 18, 2020

    Teva Paid $300M Kickbacks Through Copay Groups, Feds Say

    Teva Pharmaceuticals USA Inc. used two copay foundations to funnel more than $300 million in illegal kickbacks to Medicare patients using its multiple sclerosis drug, effectively subsidizing the treatment while steadily boosting its price, federal prosecutors alleged Tuesday.